Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quizartinib in acute myeloid leukemia.

× No keyword cloud information.

1 in total

Review 1. FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance.

Authors: Michael R Grunwald; Mark J Levis
Journal: Int J Hematol Date: 2013-04-24 Impact factor: 2.490

1 in total

7 in total

Review 1. New and emerging therapies for acute myeloid leukaemia.

Authors: Julian R Davis; David J Benjamin; Brian A Jonas
Journal: J Investig Med Date: 2018-08-19 Impact factor: 2.895

2. Research on the effect of ginseng polysaccharide on apoptosis and cell cycle of human leukemia cell line K562 and its molecular mechanisms.

Authors: Wei Xiong; Jing Li; Rong Jiang; Danyang Li; Zehong Liu; Dilong Chen
Journal: Exp Ther Med Date: 2017-01-24 Impact factor: 2.447

3. MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin.

Authors: Katja Seipel; Miguel A T Marques; Corinne Sidler; Beatrice U Mueller; Thomas Pabst
Journal: Haematologica Date: 2018-07-05 Impact factor: 9.941

4. Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia.

Authors: Jessica K Altman; James M Foran; Keith W Pratz; Denise Trone; Jorge E Cortes; Martin S Tallman
Journal: Am J Hematol Date: 2017-12-04 Impact factor: 10.047

5. Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia.

Authors: Sabrina Kraus; Martin K Kortüm; Andoni Garitano-Trojaola; Ana Sancho; Ralph Götz; Patrick Eiring; Susanne Walz; Hardikkumar Jetani; Jesus Gil-Pulido; Matteo Claudio Da Via; Eva Teufel; Nadine Rhodes; Larissa Haertle; Estibaliz Arellano-Viera; Raoul Tibes; Andreas Rosenwald; Leo Rasche; Michael Hudecek; Markus Sauer; Jürgen Groll; Hermann Einsele
Journal: Commun Biol Date: 2021-06-25

6. Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT.

Authors: Jaideep B Bharate; Nicholas McConnell; Gunaganti Naresh; Lingtian Zhang; Naga Rajiv Lakkaniga; Lucky Ding; Neil P Shah; Brendan Frett; Hong-Yu Li
Journal: Sci Rep Date: 2018-02-27 Impact factor: 4.379

7. Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.

Authors: K Reiter; H Polzer; C Krupka; A Maiser; B Vick; M Rothenberg-Thurley; K H Metzeler; D Dörfel; H R Salih; G Jung; E Nößner; I Jeremias; W Hiddemann; H Leonhardt; K Spiekermann; M Subklewe; P A Greif
Journal: Leukemia Date: 2017-08-14 Impact factor: 11.528

7 in total